DHI with the Choi implanter pen. What the literature actually says.
A short, honest read on direct implantation: how the pen actually changes the choreography, what published outcomes report, and where the comparative trials don't exist yet.
What it is.
DHI — direct hair implantation — replaces the two-step FUE sequence (open the channel, then place the graft) with a single combined motion. The instrument is the Choi implanter pen: a hollow needle 0.5–1.5 mm in diameter with a spring-loaded plunger. The graft is loaded into the needle at the bench, the surgeon advances the tip into the scalp at the chosen angle and depth, and the plunger releases the follicle as the needle withdraws.
The technique exists for one reason and one reason only: it shortens the time a follicle spends outside the body. In conventional FUE, grafts can sit in holding solution for 1–2 hours between extraction and implantation. With an implanter-pen workflow, that interval drops to minutes. The published rationale is that less ischaemic stress means higher graft viability at the recipient site, and that the in-needle delivery gives tighter control over hairline density.
The technique.
An ISHRS-trained surgeon draws the hairline on a mirror, with the patient, before any anaesthetic is given. As in FUE, hairline design is the variable that distinguishes a natural result from a transplant-looking one — and it is a single-operator decision, not delegated.
Donor extraction uses 0.81–0.90 mm circular punches under loupe magnification. Grafts are trimmed, loaded into Choi implanter needles by trained technicians, and handed to the surgeon in rotation. The needle bore is matched to graft caliber — typically 0.6–1.0 mm — so the wound is sized precisely to the follicle rather than to a generic blade.
Implantation proceeds graft by graft, with the surgeon controlling depth, angle, and inter-graft spacing in one motion. Park, Ho and Manonukul (2023) describe the practical mechanics of the sharp-implanter method, including the grip and trajectory that minimise the graft-popping problem that drives technicians mad in conventional placement. Refrigerated holding solution keeps follicular viability above 95% over a 4–5 hour case (Nerkar et al., 2025).
What the outcomes data shows.
The largest dataset on implanter outcomes is Lee et al. (2006, Dermatologic Surgery, n=1,860 single-hair follicular units across density gradients), which reports 12-month graft survival in the 87–95% range with the Korean KNU implanter, the device family the Choi pen belongs to. Earlier work from the same group (Lee et al., 2001) established the survival baseline that all subsequent implanter studies measure against.
Sethi and Bansal (2013) is the canonical paper on direct hair transplantation as a clinical workflow — 29 patients, grafts implanted within minutes of harvest, with the explicit rationale that hydration, temperature and reduced mechanical handling all improve when out-of-body time shortens. The paper does not claim DHI outperforms FUE; it argues that the workflow protects what FUE can lose.
There is no large randomised controlled trial directly comparing implanter-pen DHI against forceps-implanted FUE for 12-month graft survival as a primary endpoint. As Feller and Bloxham have noted in clinical commentary, the implanter is a plausible engineering improvement that has not been validated by side-by-side RCT data. Patient-reported naturalness scores for hairline-focused DHI sit in the 4.4–4.8 out of 5 range across published cohorts — within the same band as FUE, with the variable that moves the number being hairline design, not pen versus forceps.
What we still study.
The marketing claim that DHI delivers higher graft survival than FUE is not supported by the existing comparative literature. What is supported is shorter out-of-body time, tighter inter-graft spacing in the recipient area, and a smoother technician-surgeon hand-off that scales well in a single-day workflow. These are real, but they are workflow advantages, not biological ones.
Surgeon volume and technique remain the dominant variables in every published comparative study. A high-volume DHI programme will outperform a low-volume FUE programme. A high-volume FUE programme will outperform a low-volume DHI programme. The pen is a second-order variable behind the hand that holds it.
The Hektor protocol.
We use the Choi implanter for hairline reconstruction and high-density recipient zones — the two areas where its inter-graft control matters most — and the standard FUE workflow for diffuse coverage where it does not. Grafts are kept in chilled HypoThermosol or saline + ATP between extraction and implantation; out-of-body time per graft is logged.
We audit patient-rated naturalness at the 12-month review — a single-question scale from 1 to 5, asked by an independent coordinator rather than the operating surgeon — alongside before-and-after photography under matched lighting. The 4.7/5 figure on our cards is the mean of 412 consecutive DHI cases reviewed against the ISHRS 2023 hairline-density framework. We do not market implanter-pen DHI as a higher-survival technique because the comparative literature does not support that claim.
- ·Norwood pattern 2–5 in men, stable for 12+ months, with a hairline or dense-packing requirement
- ·Ludwig pattern I–II in women, after dermatology workup, where graft placement direction matters
- ·Sufficient donor density (≥60 follicular units / cm² at the occiput)
- ·Patients prioritising recipient-area density over total graft volume
- ·Age 25 or older (under-25 patients require a stabilisation interval)
- ·Healthy enough for local anaesthesia and a 5-hour seated procedure
- —Active scarring alopecia (lichen planopilaris, frontal fibrosing alopecia)
- —Unresolved diffuse alopecia or acute telogen effluvium
- —Pregnancy or breastfeeding
- —Active eczema, psoriasis, or infection at the recipient site
- —Uncontrolled bleeding disorders or anticoagulation that cannot be paused
- —Coverage requirements above ~3,000 grafts — DHI rate is slower per graft than FUE, and very large sessions are routed back to standard FUE
Norwood 5–6 patients with a strong donor sometimes ask for DHI across the entire coverage area. The honest answer is that the implanter's advantage concentrates in the hairline and dense-pack zones; we offer a hybrid plan — DHI hairline + frontal third, standard FUE for the crown — and document the choice in the consent.
Patients who specifically request a no-shave DHI sit in a smaller candidate pool because the implanter workflow is slower and the loading bench needs visual access to the donor. We refer those cases to the unshaven-FUE article and revisit DHI only if total graft count fits the no-shave ceiling.
Recovery, by milestone.
Compared to alternatives.
FUE opens the channel first, then places the graft with forceps. DHI combines the two motions inside the implanter needle. The published survival numbers overlap; the implanter's real advantage is shorter out-of-body time per graft and tighter hairline-density control. For diffuse-coverage cases above ~3,000 grafts, standard FUE is faster and we route the case there.PMID 40439233
FUT yields more grafts per session and avoids the donor dot-extraction pattern, but leaves a linear donor scar and is incompatible with the DHI implantation workflow. We do not offer FUT — patients seeking it are referred to a sibling brand.
Robotic extraction automates the donor-harvest step but does not address the implantation side, which is where DHI concentrates its control. The two are complementary in principle and competitive in practice — we use manual punches with a high-volume operator rather than the robot because the operator's tactile feedback on punch depth still outperforms automated systems in our hands.
Not the same product. DHI is permanent biological hair grown from transplanted follicles; replacement systems are non-surgical, reversible, and require ongoing maintenance. We do not maintain or sell replacement systems.
- ·The DHI procedure with Choi implanter pens (up to ~3,000 grafts in a single session)
- ·Pre-op consultation, trichoscopy, blood work
- ·Hairline design with the operating surgeon
- ·Daycase suite, all medications, post-op kit
- ·Translator (8 languages)
- ·Airport transfers + optional hotel night
- ·12 months of structured video follow-up with the operating surgeon
- ·Year-12 trichoscopic audit + patient-rated naturalness review + handover file to your home GP
The UK/US/EU figures are typical-range benchmarks for premium private clinics offering equivalent technique + follow-up, not Hektor quotes. They are sourced from publicly published 2024–2025 clinic price pages and ISHRS member-clinic surveys. DHI typically prices 5–15% above standard FUE in every market because of the slower per-graft rate.
Our Istanbul figure is a locked package — one number, paid once, with the inclusions above. We do not graft-bill (no per-graft surcharge) and we do not upsell post-op products.
Common questions.
Does DHI produce more growing grafts than FUE?+
How many grafts can be placed in a single DHI session?+
Is DHI better for the hairline?+
Will my hair need to be shaved for DHI?+
When will I see the final result?+
Will the donor area be noticeable afterwards?+
Can the transplanted hair fall out years later?+
What is shock loss, and is it a problem?+
Why is DHI more expensive than standard FUE?+
Why is the cost in Istanbul lower than UK or US?+
Book this procedure.
A specialist-signed plan in 24 hours, with the bibliography for your specific candidacy attached. The deposit holds the day; the package is one number.
Book a day